Evoke Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 194.1%.

Top 25 shareholders own 52.64% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.3%	Nantahala Capital Management, LLC	84,686	€554.3k	50.6%	0.04%
8.74%	Laurence Lytton	71,610	€468.7k	0%	no data
8.61%	Aigh Capital Management, LLC	70,546	€461.8k	0%	0.16%
8.39%	Bleichroeder LP	68,749	€450.0k	0%	0.09%
7.48%	Lytton-Kambara Foundation, Endowment Arm	61,274	€401.1k	0%	39.24%
7.04%	Altium Capital Management LP	57,703	€377.7k	-4.48%	0.12%
0.51%	Geode Capital Management, LLC	4,140	€27.1k	83.6%	no data
0.3%	The Vanguard Group, Inc.	2,487	€16.3k	0%	no data
0.29%	David Gonyer	2,360	€15.4k	0%	no data
0.28%	Cam Garner	2,331	€15.3k	0%	no data
0.2%	Matthew D'Onofrio	1,653	€10.8k	0%	no data
0.12%	Citadel Advisors LLC	992	€6.5k	0%	no data
0.11%	State Street Global Advisors, Inc.	888	€5.8k	0%	no data
0.076%	Tower Research Capital Europe Limited	623	€4.1k	0.97%	no data
0.051%	Mark Kowieski	417	€2.7k	0%	no data
0.044%	Marilyn Carlson	360	€2.4k	0%	no data
0.016%	Malcolm Hill	134	€877.3	0%	no data
0.015%	BlackRock, Inc.	121	€792.0	0%	no data
0.011%	UBS Asset Management AG	92	€602.2	0%	no data
0.0038%	Morgan Stanley, Investment Banking and Brokerage Investments	31	€202.7	0%	no data
0.0034%	Todd Brady	28	€183.4	0%	no data
0.0021%	NewEdge Advisors, LLC	17	€111.5	0%	no data
0.00061%	Strategic Advisers LLC	5	€32.7	0%	no data
0.00061%	Bank of America Corporation, Asset Management Arm	5	€32.7	0%	no data
0.00024%	Royal Bank of Canada, Banking & Securities Investments	2	€12.9	0%	no data